معرفی
Prof Rameen Shakur is a Professor of Genomics and Precision Medicine and Director of the Brighton Integrative Genomics Unit at the University of Brighton's School of Applied Sciences. His research focuses on cardiovascular development, inherited cardiac diseases, and precision medicine applications. He holds advanced training in molecular biology (PhD from the University of Cambridge) and clinical cardiology (Harvard Medical School, Mayo Clinic), with postdoctoral work at MIT's Koch Institute under Prof Bob Langer. He has pioneered work in genome editing (Isabelle Buohon Award recipient) and drug delivery systems (US patents in AI-driven diagnostics).
- Educations: PhD (Cambridge, 2017), MPhil Immunology (Cambridge, 2001), MBChB (Edinburgh, 2006), clinical training at Oxford/John Radcliffe Hospital
Research interests include systems biology approaches to cardiogenesis, novel biomarker discovery, and translational therapies for inherited cardiomyopathies. He advocates active learning in medical education (Kauffman Teaching Fellow, MIT 2018) and leads interdisciplinary teams in omics-driven disease prevention (MRC-funded project on heterogeneous tissue analysis).
- Awards: Isabelle Buohon Award (2017), Kauffman Teaching Fellowship (2018)
Advisory roles include directorship of medtech startups and leadership in national/international health committees. His lab integrates computational modeling with in vitro human-induced pluripotent stem cell (hIPSC) systems to advance personalized medicine.
